Literature DB >> 31542435

Tracing the Equilibrium Phase of Cancer Immunoediting in Epidermal Neoplasms via Longitudinal Intravital Imaging.

Bradley J Kubick1, Xiying Fan1, Acacia Crouch1, Riley McCarthy1, Dennis R Roop2.   

Abstract

Recognition of transformed cells by the immune system can sometimes generate a rate-limiting equilibrium phase, wherein tumor outgrowth is prevented without complete neoplasm elimination. Targeting premalignancies during this immune-controlled bottleneck is a promising strategy for rational cancer prevention. Thus far, immune equilibrium has been difficult to model in a traceable way, and most immunoediting systems have been limited to mesenchymal tumor types. Here, we introduce a mouse model for fluorescent tracing of somatic epithelial transformation. We demonstrate that transplantation can be used to prevent a confounding artificial tolerance that affects autochthonous inducible models. Using this system, we observe the expected dichotomy of outcomes: immune-deficient contexts permit rapid tumorigenesis, whereas initiated clones in immunocompetent mice undergo elimination or equilibrium. The equilibrium phase correlates with localization within hair follicles, which have been characterized previously as relatively immune-privileged sites. Given this, we posit that valleys in the immune surveillance landscape of a normal tissue can provide a cell-extrinsic alternative to the canonical cell-intrinsic adaptations believed to establish the equilibrium phase. Our model is a prototype for tracing immunoediting in vivo and could serve as a novel screening platform for therapies targeted against immune-controlled premalignancies.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31542435      PMCID: PMC7080593          DOI: 10.1016/j.jid.2019.08.446

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  3 in total

1.  Investigation of the RB1-SOX2 axis constitutes a tool for viral status determination and diagnosis in Merkel cell carcinoma.

Authors:  Soumanth Thanguturi; Anne Tallet; Elodie Miquelestorena-Standley; Catherine Coco; Yannick Le Corre; Ewa Hainaut-Wierzbicka; Astrid Blom; Philippe Saiag; Nathalie Beneton; Guido Bens; Julia Zaragoza; Charlee Nardin; François Aubin; Monica Dinulescu; Marie-Christine Machet; Roland Houben; David Schrama; Christine Collin; Gaëlle Fromont; Marie-Laure Jullie; Nicolas Macagno; Pauline Gaboriaud; Patricia Berthon; Antoine Touzé; Serge Guyétant; Mahtab Samimi; Thibault Kervarrec
Journal:  Virchows Arch       Date:  2022-04-12       Impact factor: 4.064

Review 2.  Innate lymphoid cells in early tumor development.

Authors:  Kathrin Warner; Maryam Ghaedi; Douglas C Chung; Nicolas Jacquelot; Pamela S Ohashi
Journal:  Front Immunol       Date:  2022-08-12       Impact factor: 8.786

Review 3.  Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response.

Authors:  Michelle von Locquenghien; Catalina Rozalén; Toni Celià-Terrassa
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.